Fuminori Sakurai Selected Research

adenovirus associated RNA (VA RNA)

1/2017	Enhanced Oncolytic Activities of the Telomerase-Specific Replication-Competent Adenovirus Expressing Short-Hairpin RNA against Dicer.
1/2017	MicroRNA miR-27 Inhibits Adenovirus Infection by Suppressing the Expression of SNAP25 and TXN2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fuminori Sakurai Research Topics

Disease

27	Neoplasms (Cancer) 06/2022 - 09/2003
15	Infections 01/2022 - 08/2007
5	Circulating Neoplastic Cells 05/2018 - 01/2013
4	Liver Diseases (Liver Disease) 01/2018 - 02/2011
2	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2003
2	Virus Diseases (Viral Diseases) 04/2022 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 04/2022 - 07/2017
2	Communicable Diseases (Infectious Diseases) 02/2022 - 11/2012
2	Coinfection 01/2021 - 08/2004
2	Inflammation (Inflammations) 01/2020 - 02/2007
2	Carcinoma (Carcinomatosis) 01/2018 - 09/2003
2	Hemophilia B (Haemophilia B) 01/2018 - 09/2017
2	Liver Failure 01/2017 - 05/2016
1	Insulin Resistance 04/2022
1	COVID-19 02/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2022
1	Ebola Hemorrhagic Fever 02/2022
1	Postoperative Hemorrhage 12/2021
1	Pelvic Organ Prolapse 12/2021
1	Reoviridae Infections 05/2021
1	Hepatocellular Carcinoma (Hepatoma) 05/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Colitis 01/2020
1	Lung Neoplasms (Lung Cancer) 05/2018
1	Adenocarcinoma of Lung 05/2018
1	Hematuria 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2017
1	Teratoma (Teratoid Tumor) 12/2017
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 09/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2017
1	Fistula 01/2017
1	Cholestasis 01/2017
1	Urinary Incontinence 01/2017

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 06/2022 - 09/2007
6	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2022 - 01/2013
5	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2010
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2013
4	CathepsinsIBA 05/2021 - 01/2015
4	adenovirus receptorIBA 03/2021 - 10/2007
4	CytokinesIBA 01/2020 - 09/2003
3	Double-Stranded RNA (RNA, Double Stranded)IBA 12/2021 - 05/2015
3	Neutralizing AntibodiesIBA 01/2021 - 11/2016
3	Capsid Proteins (Capsid Protein)IBA 03/2019 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 05/2018 - 11/2012
3	Pharmaceutical PreparationsIBA 01/2018 - 02/2011
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 07/2017
2	VaccinesIBA 02/2022 - 11/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 05/2017
2	InterferonsIBA 01/2021 - 01/2015
2	AntibodiesIBA 01/2018 - 01/2018
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2018 - 09/2017
2	adenovirus associated RNA (VA RNA)IBA 01/2017 - 01/2017
2	A-130A (A 130)IBA 10/2008 - 10/2008
2	Thymidine KinaseIBA 10/2008 - 10/2008
2	Ganciclovir (Cytovene)FDA LinkGeneric 10/2008 - 10/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007 - 09/2003
1	VimentinIBA 06/2022
1	Adenosine Diphosphate (ADP)IBA 04/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Domperidone (Domperidon)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 12/2021
1	Biological ProductsIBA 12/2021
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 05/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	pimonidazoleIBA 03/2019
1	Anaplastic Lymphoma KinaseIBA 05/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	LY 341495IBA 01/2018
1	pirarubicinIBA 01/2018
1	Keratins (Keratin)IBA 01/2018
1	metabotropic glutamate receptor 2IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 05/2017
1	Liposomes (Liposome)IBA 05/2017
1	Epithelial Cell Adhesion MoleculeIBA 05/2017
1	myrcludex-BIBA 01/2017
1	sodium-bile acid cotransporterIBA 01/2017
1	EndoribonucleasesIBA 01/2017
1	NucleosidesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	SNARE Proteins (SNAREs)IBA 01/2017
1	entecavir FDA Link 01/2017
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 01/2017
1	ThioredoxinsIBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	Reverse Transcriptase InhibitorsIBA 01/2017

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2011
2	Liver Transplantation 01/2018 - 03/2010
2	Transplantation 12/2017 - 05/2016
2	Intravenous Administration 02/2011 - 09/2003
1	Sutures (Suture) 12/2021
1	Length of Stay 12/2021
1	Nephrectomy 03/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Cesarean Section (Caesarean Section) 01/2017